Rab7A regulates tau secretion

Lilia Rodriguez1,2,3, Nguyen-Vi Mohamed1,2,3, Alexandre Desjardins1,2,3

  • 1Research Center of the University of Montreal Hospital (CRCHUM), Montréal, Québec, Canada.

Journal of Neurochemistry
|February 22, 2017
PubMed

Insights

Rab7A regulates the secretion of TAU protein, a key factor in Alzheimer's disease (AD) pathology. This finding suggests that increased RAB7A in AD brains may worsen TAU spread and disease progression.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Biochemistry

Background:

  • TAU protein is implicated in Alzheimer's disease (AD) and can spread extracellularly.
  • Rab7A, a small GTPase, is involved in intracellular trafficking and is upregulated in AD.

Purpose of the Study:

  • To investigate the role of Rab7A in the secretion of TAU protein.
  • To test the hypothesis that Rab7A regulates TAU secretion.

Main Methods:

  • Utilized primary cortical neurons and HeLa cells overexpressing human TAU.
  • Assessed TAU secretion following Rab7A deletion or manipulation of its activity (dominant-negative and constitutively active forms).
  • Examined co-localization of TAU and Rab7-positive structures.

Main Results:

  • Rab7A deletion significantly decreased TAU secretion.
  • Overexpression of dominant-negative Rab7A reduced TAU secretion, while constitutively active Rab7A increased it.
  • Partial co-localization of TAU and Rab7 suggests involvement of late endosomes in secretion.

Conclusions:

  • Rab7A plays a regulatory role in TAU secretion.
  • Upregulation of RAB7A in AD may contribute to extracellular TAU accumulation and pathology propagation.